drugset / Trial / NCT06122948

Effect of Intranasal Midazolam Versus Ketamine Midazolam Combination as a Premedication on the Occurrence of Postoperative Respiratory Adverse Events

NCT06122948

Phase 3 Completed 200 enrolled Kasr El Aini Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of this study is to investigate the effect of addition of intranasal ketamine to midazolam compared to midazolam alone as a premedication on the occurrence of PRAEs

Timeline

Start
2023-11-04
Primary completion
2024-10-10
Completion
2024-10-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 3 mg/kg Intranasal
Comparator Midazolam Small molecule 0.1 mg/kg Intranasal